Kalos Management Inc. Acquires 1,821 Shares of CVS Health Corp (CVS)

Kalos Management Inc. lifted its holdings in shares of CVS Health Corp (NYSE:CVS) by 9.2% during the third quarter, HoldingsChannel.com reports. The firm owned 21,644 shares of the pharmacy operator’s stock after acquiring an additional 1,821 shares during the quarter. Kalos Management Inc.’s holdings in CVS Health were worth $1,760,000 at the end of the most recent quarter.

Several other large investors have also modified their holdings of the company. Jackson Grant Investment Advisers Inc. lifted its holdings in CVS Health by 0.6% in the second quarter. Jackson Grant Investment Advisers Inc. now owns 2,881 shares of the pharmacy operator’s stock valued at $232,000 after buying an additional 18 shares during the period. Traynor Capital Management Inc. lifted its holdings in CVS Health by 1.3% in the second quarter. Traynor Capital Management Inc. now owns 3,676 shares of the pharmacy operator’s stock valued at $290,000 after buying an additional 48 shares during the period. Sequoia Financial Advisors LLC lifted its holdings in CVS Health by 0.8% in the second quarter. Sequoia Financial Advisors LLC now owns 6,406 shares of the pharmacy operator’s stock valued at $515,000 after buying an additional 53 shares during the period. Brookstone Capital Management lifted its holdings in CVS Health by 1.8% in the second quarter. Brookstone Capital Management now owns 3,153 shares of the pharmacy operator’s stock valued at $254,000 after buying an additional 55 shares during the period. Finally, Mengis Capital Management Inc. lifted its holdings in CVS Health by 0.7% in the second quarter. Mengis Capital Management Inc. now owns 11,415 shares of the pharmacy operator’s stock valued at $918,000 after buying an additional 75 shares during the period. Institutional investors own 81.69% of the company’s stock.

Shares of CVS Health Corp (NYSE CVS) opened at $69.39 on Friday. The company has a current ratio of 1.02, a quick ratio of 0.55 and a debt-to-equity ratio of 0.59. The company has a market cap of $71,466.59, a PE ratio of 10.72, a PEG ratio of 1.18 and a beta of 0.93. CVS Health Corp has a 52-week low of $66.45 and a 52-week high of $84.00.

CVS Health (NYSE:CVS) last posted its earnings results on Thursday, February 8th. The pharmacy operator reported $1.92 EPS for the quarter, topping the consensus estimate of $1.88 by $0.04. The company had revenue of $48.39 billion during the quarter, compared to the consensus estimate of $47.54 billion. CVS Health had a net margin of 3.58% and a return on equity of 17.21%. The firm’s revenue for the quarter was up 5.3% on a year-over-year basis. During the same period in the previous year, the firm posted $1.71 earnings per share. research analysts anticipate that CVS Health Corp will post 6.49 EPS for the current year.

The firm also recently announced a quarterly dividend, which was paid on Friday, February 2nd. Stockholders of record on Wednesday, January 24th were given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 2.88%. The ex-dividend date was Tuesday, January 23rd. CVS Health’s payout ratio is presently 30.91%.

Several equities analysts recently issued reports on the stock. Loop Capital dropped their target price on shares of CVS Health from $83.00 to $73.00 and set a “hold” rating on the stock in a report on Tuesday, November 7th. Morgan Stanley upgraded shares of CVS Health from an “equal weight” rating to an “overweight” rating and set a $88.00 target price on the stock in a report on Friday, January 5th. Needham & Company LLC upped their price objective on shares of CVS Health from $85.00 to $88.00 and gave the company a “buy” rating in a report on Tuesday, January 2nd. SunTrust Banks upped their price objective on shares of CVS Health to $90.00 and gave the company a “buy” rating in a report on Friday, January 5th. Finally, Leerink Swann set a $85.00 price objective on shares of CVS Health and gave the company a “buy” rating in a report on Friday. Two analysts have rated the stock with a sell rating, seven have assigned a hold rating, twelve have given a buy rating and two have issued a strong buy rating to the company. The stock presently has a consensus rating of “Buy” and an average target price of $87.77.

In other news, EVP Lisa Bisaccia sold 29,445 shares of the business’s stock in a transaction dated Thursday, December 21st. The shares were sold at an average price of $75.00, for a total transaction of $2,208,375.00. Following the completion of the sale, the executive vice president now directly owns 15,556 shares of the company’s stock, valued at $1,166,700. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Insiders own 0.61% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Kalos Management Inc. Acquires 1,821 Shares of CVS Health Corp (CVS)” was originally reported by Community Financial News and is the sole property of of Community Financial News. If you are reading this report on another publication, it was stolen and reposted in violation of United States and international copyright and trademark laws. The correct version of this report can be viewed at https://www.com-unik.info/2018/02/10/kalos-management-inc-acquires-1821-shares-of-cvs-health-corp-cvs.html.

CVS Health Company Profile

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit